American pharmaceutical companies Pfizer and German Biontech began to work on the adaptation of their vaccine from Coronavirus under the new strain “Oomikron”, reports Bloomberg with reference to the company’s statement.
The new version of the drug may appear for 100 days.
The company began work last Thursday, when it became aware of the new strain. To begin with, Pfizer and Biontech will study to understand whether the development of a new vaccine is required.